These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Innate and Adaptive Immune Regulation During Chronic Viral Infections. Zuniga EI; Macal M; Lewis GM; Harker JA Annu Rev Virol; 2015 Nov; 2(1):573-97. PubMed ID: 26958929 [TBL] [Abstract][Full Text] [Related]
5. IL-10: achieving balance during persistent viral infection. Ng CT; Oldstone MB Curr Top Microbiol Immunol; 2014; 380():129-44. PubMed ID: 25004816 [TBL] [Abstract][Full Text] [Related]
6. The role of IL-10 in regulating immunity to persistent viral infections. Wilson EB; Brooks DG Curr Top Microbiol Immunol; 2011; 350():39-65. PubMed ID: 20703965 [TBL] [Abstract][Full Text] [Related]
7. Decoding the complexity of type I interferon to treat persistent viral infections. Wilson EB; Brooks DG Trends Microbiol; 2013 Dec; 21(12):634-40. PubMed ID: 24216022 [TBL] [Abstract][Full Text] [Related]
8. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Brooks DG; Ha SJ; Elsaesser H; Sharpe AH; Freeman GJ; Oldstone MB Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20428-33. PubMed ID: 19075244 [TBL] [Abstract][Full Text] [Related]
9. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Ha SJ; West EE; Araki K; Smith KA; Ahmed R Immunol Rev; 2008 Jun; 223():317-33. PubMed ID: 18613845 [TBL] [Abstract][Full Text] [Related]
10. Exhaustion and Inflation at Antipodes of T Cell Responses to Chronic Virus Infection. Cicin-Sain L; Arens R Trends Microbiol; 2018 Jun; 26(6):498-509. PubMed ID: 29249600 [TBL] [Abstract][Full Text] [Related]
11. Immune Checkpoints in Viral Infections. Cai H; Liu G; Zhong J; Zheng K; Xiao H; Li C; Song X; Li Y; Xu C; Wu H; He Z; Zhu Q Viruses; 2020 Sep; 12(9):. PubMed ID: 32967229 [TBL] [Abstract][Full Text] [Related]
12. [Viral interactions with the host's immune system]. Humlová Z Sb Lek; 2001; 102(3):329-39. PubMed ID: 12092118 [TBL] [Abstract][Full Text] [Related]
14. The role of antibody and complement in the control of viral infections. Cooper NR; Nemerow GR J Invest Dermatol; 1984 Jul; 83(1 Suppl):121s-127s. PubMed ID: 6376646 [TBL] [Abstract][Full Text] [Related]
15. New insights into type I interferon and the immunopathogenesis of persistent viral infections. Snell LM; Brooks DG Curr Opin Immunol; 2015 Jun; 34():91-8. PubMed ID: 25771184 [TBL] [Abstract][Full Text] [Related]
16. Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions. Fuse S; Molloy MJ; Usherwood EJ Crit Rev Immunol; 2008; 28(2):159-83. PubMed ID: 18540829 [TBL] [Abstract][Full Text] [Related]